OQS
RLAY icon

Occudo Quantitative Strategies’s Relay Therapeutics RLAY Stock Holding History

Occudo Quantitative Strategies’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,092
Closed -$196K – 1156
2022
Q4 		$196K Buy
13,092
+2,107
+19% +$40.3K 0.02% 784
2022
Q3 		$246K Buy
+10,985
New +$241K 0.02% 909

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Occudo Quantitative Strategies's RLAY Position: Q1 2023 in Review

Occudo Quantitative Strategies sold out of Relay Therapeutics (RLAY) in Q1 2023, closing a stake of 13,092 shares — an estimated $196K sold.

Occudo Quantitative Strategies first reported a position in RLAY in Q3 2022 and held it in 2 quarters. The position peaked at $246K in Q3 2022. 157 funds tracked by Wall St. Rank hold RLAY as of Q1 2023.

  • Occudo Quantitative Strategies reported no remaining Relay Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 13,092 Relay Therapeutics shares in Q1 2023, an estimated $196K.
  • Occudo Quantitative Strategies first reported a position in Relay Therapeutics in Q3 2022 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Relay Therapeutics position peaked at $246K in Q3 2022.
  • 157 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2023, filed 15 May 2023.